These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 1794261)

  • 41. Rationale for the association of sulfonylurea and insulin.
    Del Prato S
    Am J Med; 1991 Jun; 90(6A):77S-82S. PubMed ID: 1872309
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Effects of the combination of insulin and gliclazide compared with insulin alone in type 2 diabetic patients with secondary failure to oral hypoglycemic agents.
    Aschner P; Kattah W
    Diabetes Res Clin Pract; 1992 Oct; 18(1):23-30. PubMed ID: 1446575
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Free radical scavenging activity of sulfonylureas: a clinical assessment of the effect of gliclazide.
    Jennings PE; Belch JJ
    Metabolism; 2000 Feb; 49(2 Suppl 1):23-6. PubMed ID: 10693916
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Effect of gliclazide on non-insulin dependent diabetes mellitus.
    Wajchenberg BJ; Santomaruo AT; Cherem JJ; Malerbi DA; Giurno Filho A; Lerario AC; Giannella Neto D
    Adv Exp Med Biol; 1988; 246():313-9. PubMed ID: 3074661
    [No Abstract]   [Full Text] [Related]  

  • 45. Determining the most appropriate treatment for patients with non-insulin-dependent diabetes mellitus.
    Cooppan R
    Metabolism; 1987 Feb; 36(2 Suppl 1):17-21. PubMed ID: 3543617
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Management of non-insulin-dependent diabetes mellitus.
    Lefèbvre PJ; Scheen AJ
    Drugs; 1992; 44 Suppl 3():29-38. PubMed ID: 1280575
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Effect of sulphonylurea administration on insulin secretion and amino acid metabolism in non-insulin-dependent diabetic patients.
    Paterson KR; Gyi KM; McBride D; Cohen HN; Shenkin A; Manderson WG; MacCuish AC
    Diabet Med; 1985 Jan; 2(1):38-40. PubMed ID: 2951064
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Short- and long-term gliclazide effects on pancreatic islet cell function and hepatic insulin extraction in non-insulin-dependent diabetes mellitus.
    Wajchenberg BL; Santomauro AT; Giannella-Neto D; Borghi VC; Porrelli RN
    Diabetes Res Clin Pract; 1992 Aug; 17(2):89-97. PubMed ID: 1425152
    [TBL] [Abstract][Full Text] [Related]  

  • 49. The clinical use of oral sulfonylureas in the management of non-insulin dependent diabetes mellitus (NIDDM).
    Ponte CD
    W V Med J; 1990 Oct; 86(10):455-8. PubMed ID: 2238629
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Gliclazide modified release: its place in the therapeutic armamentarium.
    Crepaldi G; Fioretto P
    Metabolism; 2000 Oct; 49(10 Suppl 2):21-5. PubMed ID: 11078472
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Combined insulin-sulfonylurea therapy in treatment of NIDDM.
    Groop LC; Groop PH; Stenman S
    Diabetes Care; 1990 Aug; 13 Suppl 3():47-52. PubMed ID: 2209344
    [TBL] [Abstract][Full Text] [Related]  

  • 52. [Diamicron in the treatment of diabetes mellitus type 2].
    Balabolkin MI; Morozova TP; Chachiashvili MV
    Sov Med; 1987; (7):21-2. PubMed ID: 3317910
    [No Abstract]   [Full Text] [Related]  

  • 53. Antidiabetic agents.
    Francisco GE
    Prim Care; 1990 Sep; 17(3):499-519. PubMed ID: 2236334
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Is it time to re-assess the role of gliclazide? Targeting insulin resistance in type 2 diabetes patients suboptimally controlled with insulin.
    Brown N
    Postgrad Med J; 2006 Jul; 82(969):471-5. PubMed ID: 16822926
    [TBL] [Abstract][Full Text] [Related]  

  • 55. [Sulfonylureas in today's blood glucose lowering therapy. New data on advantages and potential barriers of an "old" antidiabetic group].
    Winkler G
    Orv Hetil; 2015 Mar; 156(13):511-5. PubMed ID: 25796278
    [TBL] [Abstract][Full Text] [Related]  

  • 56. [Gliclazide: review of metabolic and vascular action].
    Alberti KG
    Diabete Metab; 1994 Nov; 20(3 Pt 2):341-8. PubMed ID: 7828778
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Mortality outcomes of different sulphonylurea drugs: the results of a 14-year cohort study of type 2 diabetic patients.
    Bo S; Castiglione A; Ghigo E; Gentile L; Durazzo M; Cavallo-Perin P; Ciccone G
    Eur J Endocrinol; 2013 Jul; 169(1):117-26. PubMed ID: 23660643
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Type II diabetic subjects with secondary failure: treatment with prebreakfast mixed ultralente and regular insulin with a sulfonylurea.
    Kabadi UM; Kabadi MU
    J Fam Pract; 1991 Oct; 33(4):349-53. PubMed ID: 1919450
    [TBL] [Abstract][Full Text] [Related]  

  • 59. [Physiopathology of non-insulin-dependent diabetes. New therapeutic approaches with gliclazide].
    Lesobre B
    Journ Annu Diabetol Hotel Dieu; 1988; ():337-47. PubMed ID: 3050231
    [No Abstract]   [Full Text] [Related]  

  • 60. Exercise in the management of non-insulin-dependent diabetes mellitus.
    Wallberg-Henriksson H; Rincon J; Zierath JR
    Sports Med; 1998 Jan; 25(1):25-35. PubMed ID: 9458525
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.